Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke

This study aims to evaluate whether initiating intravenous tirofiban within 48 hours of onset (with a 48-hour infusion), followed by sequential DAPT, can improve the likelihood of excellent functional outcomes (modified Rankin Scale score 0-1) in mild stroke patients, compared with standard DAPT therapy based on current guidelines.

NCT Number	NCT07095790
Lead Sponsor	Second Affiliated Hospital of Soochow University
Conditions	Mild Stroke
Enrollment	580 participants
Start Date	2025-08-30
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-31